Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension.

Cavelier, Marine; Gondé, Henri; Costa, Damien; Lamoureux, Fabien; Pereira, Tony; Buchbinder, Nimrod; Varin, Rémi; Hervouët, Charles

Cavelier, Marine; Gondé, Henri; Costa, Damien; Lamoureux, Fabien; Pereira, Tony; Buchbinder, Nimrod; Varin, Rémi; Hervouët, Charles.

Afiliación

Cavelier M; CHU Rouen, Department of Pharmacy, F-76000 Rouen, France.
Gondé H; CHU Rouen, Department of Pharmacy, Normandie University, UNIROUEN, U1234, F-76000 Rouen, France.
Costa D; CHU Rouen, Department of Parasitology-Mycology, Normandie University, UNIROUEN, EA7510 ESCAPE, F-76000 Rouen, France.
Lamoureux F; CHU Rouen, Department of Pharmacology, F-76000 Rouen, France.
Pereira T; CHU Rouen, Department of Pharmacology, F-76000 Rouen, France.
Buchbinder N; CHU Rouen, Department of Pediatric Oncology and Hematology, F-76000 Rouen, France.
Varin R; CHU Rouen, Department of Pharmacy, Normandie University, UNIROUEN, U1234, F-76000 Rouen, France.
Hervouët C; CHU Rouen, Department of Pharmacy, F-76000 Rouen, France.

Pharmaceutics ; 15(2)2023 Jan 29.

Article en En | MEDLINE | ID: mdl-36839767

Palabras clave

compounding; hypertension; nicardipine hydrochloride; oral solution; pediatric formulation; stability

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: Francia